Neoplasms of the Facial Skin

Clinics in Plastic Surgery

Volumn 36, Issue 3, 2009, Pages 319-334

  Hajdarbegovic, E ^a   van der Leest, R J T ^a   Munte, K ^a   Thio, H B ^a   Neumann, H A M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Face; Melanoma; Non melanoma; Skin tumors; Synopsis

Indexed keywords

FLUOROURACIL; IMIQUIMOD;

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; BLUE NEVUS; BOWEN DISEASE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER INVASION; CANCER MORPHOLOGY; CANCER RECURRENCE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FACE TUMOR; HUMAN; MALIGNANT LENTIGO; MELANOCYTIC NEVUS; MELANOMA; METASTASIS POTENTIAL; PHOTODYNAMIC THERAPY; REVIEW; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; SURVIVAL RATE;

FACE; HUMANS; SKIN NEOPLASMS;

EID: 66249089461     PISSN: 00941298     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cps.2009.02.007     Document Type: Review

References (59)

1. Holme S.A., Malinovszky K., and Roberts D.L. Changing trends in non-melanoma skin cancer in South Wales, 1988-98. Br J Dermatol 143 (2000) 1224-1229
2. Ko C.B., Walton S., Keczkes K., et al. The emerging epidemic of skin cancer. Br J Dermatol 130 (1994) 269-272
3. Smeets N.W., Krekels G.A., Ostertag J.U., et al. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 364 (2004) 1766-1772
4. Robinson J.K., and Dahiya M. Basal cell carcinoma with pulmonary and lymph node metastasis causing death. Arch Dermatol 139 (2003) 643-648
5. Rigel D.S., Friedman R.J., and Kopf A.W. Lifetime risk for development of skin cancer in the U.S. population: current estimate is now 1 in 5. J Am Acad Dermatol 35 (1996) 1012-1013
6. Smeets N.W., Kuijpers D.I., Nelemans P., et al. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face-results of a retrospective study and review of the literature. Br J Dermatol 151 (2004) 141-147
7. Chuang T.Y., Popescu A., Su W.P., et al. Basal cell carcinoma. A population-based incidence study in Rochester, Minnesota. J Am Acad Dermatol 22 (1990) 413-417
8. Giles G.G., Marks R., and Foley P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J (Clin Res Ed) 296 (1988) 13-17
9. Coebergh J.W., Neumann H.A., Vrints L.W., et al. Trends in the incidence of non-melanoma skin cancer in the SE Netherlands 1975-1988: a registry-based study. Br J Dermatol 125 (1991) 353-359
10. Gallagher R.P., Ma B., McLean D.I., et al. Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987. J Am Acad Dermatol 23 (1990) 413-421
11. Kumar P., Watson S., Brain A.N., et al. Incomplete excision of basal cell carcinoma: a prospective multicentre audit. Br J Plast Surg 55 (2002) 616-622
12. Oley C.A., Sharpe H., and Chenevix-Trench G. Basal cell carcinomas, coarse sparse hair, and milia. Am J Med Genet 43 (1992) 799-804
13. Oettle A.G. Rodent ulcers in identical twins. AMA Arch Derm 74 (1956) 167-172
14. Schirren C.G., and Pfirstinger H. [On the development of squamous cell carcinoma based Onjadassohn's nevus sebaceous.]. Hautarzt 14 (1963) 397-401 [in German]
15. von Domarus H., and Stevens P.J. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 10 (1984) 1043-1060
16. Leffell D.J., Headington J.T., Wong D.S., et al. Aggressive-growth basal cell carcinoma in young adults. Arch Dermatol 127 (1991) 1663-1667
17. Cox N.H. Basal cell carcinoma in young adults. Br J Dermatol 127 (1992) 26-29
18. Kumakiri M., and Hashimoto K. Ultrastructural resemblance of basal cell epithelioma to primary epithelial germ. J Cutan Pathol 5 (1978) 53-67
19. Van Scott E.J., and Reinertson R.P. The modulating influence of stromal environment on epithelial cells studied in human autotransplants. J Invest Dermatol 36 (1961) 109-131
20. Zackheim H.S. Origin of the human basal cell epithelioma. J Invest Dermatol 40 (1963) 283-297
21. Madsen A. Studies on basal-cell epithelioma of the skin.The architecture, manner of growth, and histogenesis of the tumours. Whole tumours examined in serial sections cut parallel to the skin surface. Acta Pathol Microbiol Scand Suppl 177 (1965) 163-173
22. Rowe D.E., Carroll R.J., and Day Jr. C.L. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 15 (1989) 424-431
23. Rowe D.E., Carroll R.J., and Day Jr. C.L. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 15 (1989) 315-328
24. Mosterd K., Krekels G.A., Nieman F.H., et al. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol 9 (2008) 1149-1156
25. Burg G., Hirsch R.D., Konz B., et al. Histographic surgery: accuracy of visual assessment of the margins of basal-cell epithelioma. J Dermatol Surg 1 (1975) 21-24
26. Breuninger H., and Dietz K. Prediction of subclinical tumor infiltration in basal cell carcinoma. J Dermatol Surg Oncol 17 (1991) 574-578
27. Panje W.R., and Ceilley R.I. The influence of embryology of the mid-face on the spread of epithelial malignancies. Laryngoscope 89 (1979) 1914-1920
28. Smeets N. Workgroup basal cell carcinoma: Guideline Treatment of patients with basal cell carcinoma. Richtlijn Behandeling van patienten met basaalcelcarcinoom (2003), Publication of the quality institute for healthcare CBO, Utrecht 16-26. Available at: www.cbo.nl Accessed February 2, 2009
29. Verhaegh MEJM, Gruintjens FWG, Krekels GAM, et al. Surgical margins for excision of primary and recurrent basal cell carcinoma. [in. Maastricht] 1998;93-105.
30. Smith S.P., and Grande D.J. Basal cell carcinoma recurring after radiotherapy: a unique, difficult treatment subclass of recurrent basal cell carcinoma. J Dermatol Surg Oncol 17 (1991) 26-30
31. Robinson J.K., and Fisher S.G. Recurrent basal cell carcinoma after incomplete resection. Arch Dermatol 136 (2000) 1318-1324
32. Cook J., and Zitelli J.A. Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol 39 (1998) 698-703
33. de Vries E., van de Poll-Franse L.V., Louwman W.J., et al. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol 152 (2005) 481-488
34. Chuang T.Y., Reizner G.T., Elpern D.J., et al. Squamous cell carcinoma in Kauai, Hawaii. Int J Dermatol 34 (1995) 393-397
35. Hama N., Ohtsuka T., and Yamazaki S. Detection of mucosal human papilloma virus DNA in bowenoid papulosis, Bowen's disease and squamous cell carcinoma of the skin. J Dermatol 33 (2006) 331-337
36. Weinberg A.S., Ogle C.A., and Shim E.K. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg 33 (2007) 885-899
37. Glogau R.G. The risk of progression to invasive disease. J Am Acad Dermatol 42 (2000) 23-24
38. Fuchs A., and Marmur E. The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma. Dermatol Surg 33 (2007) 1099-1101
39. Motley R., Kersey P., and Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Plast Surg 56 (2003) 85-91
40. Rowe D.E., Carroll R.J., and Day Jr. C.L. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 26 (1992) 976-990
41. Broders A.C. Squamous-cell epithelioma of the skin: a study of 256 cases. Ann Surg 73 (1921) 141-160
42. Neville J.A., Welch E., and Leffell D.J. Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol 4 (2007) 462-469
43. Ward E.M., Thun M.J., Hannan L.M., et al. Interpreting cancer trends. Ann N Y Acad Sci 1076 (2006) 29-53
44. Geller A.C., Miller D.R., Annas G.D., et al. Melanoma incidence and mortality among US whites, 1969-1999. JAMA 288 (2002) 1719-1720
45. Moan J., Porojnicu A.C., and Dahlback A. Ultraviolet radiation and malignant melanoma. Adv Exp Med Biol 624 (2008) 104-116
46. Dennis L.K., Vanbeek M.J., Beane Freeman L.E., et al. Sunburns and risk of cutaneous melanoma: does age matter? A comprehensive meta-analysis. Ann Epidemiol 18 (2008) 614-627
47. Mocellin S., and Nitti D. Vitamin D receptor polymorphisms and the risk of cutaneous melanoma: a systematic review and meta-analysis. Cancer 113 (2008) 2398-2407
48. Watt A.J., Kotsis S.V., and Chung K.C. Risk of melanoma arising in large congenital melanocytic nevi: a systematic review. Plast Reconstr Surg 113 (2004) 1968-1974
49. Quaba A.A., and Wallace A.F. The incidence of malignant melanoma (0 to 15 years of age) arising in "large" congenital nevocellular nevi. Plast Reconstr Surg 78 (1986) 174-181
50. Bafounta M.L., Beauchet A., Aegerter P., et al. Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch Dermatol 137 (2001) 1343-1350
51. Kittler H., Pehamberger H., Wolff K., et al. Diagnostic accuracy of dermoscopy. Lancet Oncol 3 (2002) 159-165
52. Koch S.E., and Lange J.R. Amelanotic melanoma: the great masquerader. J Am Acad Dermatol 42 (2000) 731-734
53. Balch C.M., Soong S.J., Smith T., et al. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol 8 (2001) 101-108
54. Lens M.B., Nathan P., and Bataille V. Excision margins for primary cutaneous melanoma: updated pooled analysis of randomized controlled trials. Arch Surg 142 (2007) 885-891
55. Haigh P.I., DiFronzo L.A., and McCready D.R. Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis. Can J Surg 46 (2003) 419-426
56. Balch C.M., Urist M.M., Karakousis C.P., et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg 218 (1993) 262-267
57. Wright B.E., Scheri R.P., Ye X., et al. Importance of sentinel lymph node biopsy in patients with thin melanoma. Arch Surg 143 (2008) 892-899
58. Koskivuo I., Talve L., Vihinen P., et al. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study. Ann Surg Oncol 14 (2007) 3566-3574
59. Bergman W., Kruit W.H.J., Nieweg O.E., et al. Melanoma workgroup. Guideline Melanoma of the skin. Richtlijn Melanoom van de huid (2004), Publication of the quality institute for healthcare CBO, Utrecht 49-51. Available at: www.cbo.nl Accessed February 2, 2009